Kazuhiro Kajiyama

Pharmaceuticals and Medical Devices Agency, Japan

Poster(s):

• (B-250) Safety Assessment on the Risk of Liver Dysfunction by ACE Inhibitors utilizing the MID-NET® in Japan
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-251) Safety signal monitoring of an anti-COVID-19 drug in the MID-NET® in Japan
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET